{"id":"NCT02666664","sponsor":"Esperion Therapeutics, Inc.","briefTitle":"Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Multicenter Long-term Safety and Tolerability Study of ETC-1002 in Patients With Hyperlipidemia at High Cardiovascular Risk Who Are Not Adequately Controlled by Their Lipid-Modifying Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-01-21","primaryCompletion":"2018-02-21","completion":"2018-03-28","firstPosted":"2016-01-28","resultsPosted":"2020-04-20","lastUpdate":"2020-05-11"},"enrollment":2230,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia","Atherosclerotic Cardiovascular Diseases"],"interventions":[{"type":"DRUG","name":"ETC-1002","otherNames":["bempedoic acid"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"ETC-1002","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to see if ETC-1002 (bempedoic acid) is safe and well-tolerated versus placebo in patients with high cardiovascular risk and elevated LDL cholesterol that is not adequately controlled by their current therapy.","primaryOutcome":{"measure":"Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)","timeFrame":"Up to approximately 52 weeks","effectByArm":[{"arm":"Placebo","deltaMin":78.7,"sd":null},{"arm":"Bempedoic Acid","deltaMin":78.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":104,"countries":["United States","Canada","Germany","Netherlands","Poland","United Kingdom"]},"refs":{"pmids":["27892461","24222016","21600525","18537526","11535564","30865796","36813656","35916348","32609313"],"seeAlso":["http://www.who.int/mediacentre/factsheets/fs317/en/","https://thefhfoundation.org/familial-hypercholesterolemia/what-is-familial-hypercholesterolemia","https://rarediseases.org/rare-diseases/familial-hypercholesterolemia/"]},"adverseEventsSummary":{"seriousAny":{"events":216,"n":1487},"commonTop":["Nasopharyngitis","Myalgia","Urinary tract infection","Arthralgia","Upper respiratory tract infection"]}}